<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>McKesson strikes $2.25 billion Precision Medicine deal in clinical research bets — Live Feed</title><link>https://www.live-feeds.com/feed/mckesson-strikes-2-25-billion-precision-medicine-deal-in-clinical-research-bets</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/mckesson-strikes-2-25-billion-precision-medicine-deal-in-clinical-research-bets/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>McKesson acquires Precision Medicine Group for $2.25 billion</title><link>https://www.live-feeds.com/feed/mckesson-strikes-2-25-billion-precision-medicine-deal-in-clinical-research-bets</link><guid isPermaLink="false">https://www.live-feeds.com/feed/mckesson-strikes-2-25-billion-precision-medicine-deal-in-clinical-research-bets#u49363</guid><pubDate>Thu, 27 Aug 2026 00:51:17 +0000</pubDate><description>McKesson has agreed to buy Precision Medicine Group for $2.25 billion, aiming to enhance its oncology and clinical research services. The acquisition is part of McKesson&amp;#039;s efforts to bolster its portfolio and drive sustainable growth. This deal comes amid McKesson&amp;#039;s reorganization and layoffs.Why it mattersThe acquisition is a strategic move by McKesson to expand its presence in the precision medicine market. Precision Medicine Group provides clinical research services, including site management and research support. This deal is expected to drive growth in McKesson&amp;#039;s oncology a</description></item>
</channel></rss>